Next Article in Journal
A New and Rapid LC-MS/MS Method for the Determination of Cysteamine Plasma Levels in Cystinosis Patients
Next Article in Special Issue
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease
Previous Article in Journal
Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway
Previous Article in Special Issue
Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer’s Disease
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(5), 648; https://doi.org/10.3390/ph17050648
Action Date Notes Link
article xml file uploaded 16 May 2024 16:06 CEST Original file -
article xml uploaded. 16 May 2024 16:06 CEST Update https://www.mdpi.com/1424-8247/17/5/648/xml
article pdf uploaded. 16 May 2024 16:06 CEST Version of Record https://www.mdpi.com/1424-8247/17/5/648/pdf
article supplementary file uploaded. 16 May 2024 16:06 CEST - https://www.mdpi.com/1424-8247/17/5/648#supplementary
article html file updated 16 May 2024 16:08 CEST Original file https://www.mdpi.com/1424-8247/17/5/648/html
Back to TopTop